Data presented at TCT 2026 demonstrate highest sensitivity and specificity of any FFR-CT validation study BOSTON and TCT 2026, SAN DIEGO – Nov. 3, 2026 – Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at the annual Transcatheter Cardiovascular Therapeutics Conference (TCT 2026). The ELUCIDATE study, which supported Elucid’s […]